selinexor
Selinexor is a drug used to treat Multiple Myeloma, Acute Myeloid Leukemia, Glioblastoma, and other conditions. Selinexor is being actively studied in 48 studies and prior, has been studied in 20.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| Karyopharm Therapeutics Inc | H. Lee Moffitt Cancer Center and Research Institute | Bhavana Bhatnagar |
| H. Lee Moffitt Cancer Center and Research Institute | Memorial Sloan Kettering Cancer Center | Erin Bertino |
| St. Jude Children's Research Hospital | Dana Farber Cancer Institute | David E Gerber |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Recruiting
- Soft Tissue Sarcoma
- +3 more
- Selinexor
- Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
2021-03-29
Mar 29, 2021J
Not yet recruiting
- Multiple Myeloma
- Selinexor
- +4 more
- Shanghai, Shanghai, ChinaShanghai Changzheng Hospital
2021-07-02
Jul 2, 2021W
Not yet recruiting
- Amyloid
- +2 more
- Selinexor
- Dexamethasone
- New York, New York
- +1 more
2021-11-18
Nov 18, 2021H
Active, not recruiting
- Leukemia
- +2 more
- Selinexor
- +2 more
- Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
2021-11-15
Nov 15, 2021N
Completed
- Peripheral T-cell Lymphoma
- Selinexor
- ICE Chemotherapy
- Singapore, SingaporeNational Cancer Centre Singapore
2021-04-27
Apr 27, 2021U
Recruiting
- Primary Myelofibrosis
- +2 more
- Selinexor
- Salt Lake City, UtahHuntsman Cancer Institute/University of Utah
2021-09-27
Sep 27, 2021N
Recruiting
- Gliosarcoma
- +2 more
- Selinexor
- +2 more
- Bethesda, MarylandNational Institutes of Health Clinical Center
2021-10-16
Oct 16, 2021H
Active, not recruiting
- Multiple Myeloma
- Selinexor
- +2 more
- Tampa, Florida
- +1 more
2021-08-03
Aug 3, 2021G
Completed
- Acute Myeloid Leukemia (Relapsed/Refractory)
- Selinexor
- +2 more
- Frankfurt am Main, Hessen, Germany
- +2 more
2021-08-01
Aug 1, 2021W
Not yet recruiting
- Myeloma Multiple
- +2 more
- Selinexor
- +3 more
- Aurora, Colorado
- +2 more
2021-08-26
Aug 26, 2021G
Recruiting
- Sarcoma,Soft Tissue
- Selinexor
- Barcelona, Spain
- +5 more
2021-11-16
Nov 16, 2021K
Recruiting
- Metastatic Colorectal Cancer
- Selinexor
- +3 more
- Los Angeles, California
- +1 more
2021-08-27
Aug 27, 2021K
Recruiting
- Myelofibrosis
- Selinexor
- Physician's Choice Treatment
- Pasadena, California
- +2 more
2021-07-20
Jul 20, 2021K
Withdrawn
- Coronavirus Infection
- Selinexor
- (no location specified)
2020-12-03
Dec 3, 2020U
Active, not recruiting
- Soft Tissue Sarcoma
- Selinexor
- Doxorubicin
- Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
2020-09-24
Sep 24, 2020H
Active, not recruiting
- Multiple Myeloma
- Selinexor
- +4 more
- Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
2021-11-18
Nov 18, 2021M
Completed
- Ovarian Cancer
- Endometrial Cancer
- Paclitaxel
- +2 more
- Middletown, New Jersey
- +2 more
2021-04-22
Apr 22, 2021M
Recruiting
- Advanced Urothelial Carcinoma
- +3 more
- Pembrolizumab
- Selinexor
- Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
2021-04-19
Apr 19, 2021K
Recruiting
- Multiple Myeloma, Refractory
- Selinexor
- +2 more
- Patra, Achaia, Greece
- +15 more
2021-09-29
Sep 29, 2021N
Recruiting
- Advanced Refractory Solid Tumors
- +2 more
- Talazoparib
- Selinexor
- Singapore, SingaporeNational University Hospital
2021-08-31
Aug 31, 2021L
Not yet recruiting
- Multiple Myeloma
- Selinexor
- +2 more
- Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
2021-05-13
May 13, 2021K
Terminated
- Prostate Cancer
- Selinexor
- Houston, TexasM.D. Anderson Cancer Center
2021-01-07
Jan 7, 2021H
Completed
- Breast Cancer
- Selinexor
- Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
2020-09-09
Sep 9, 2020T
Active, not recruiting
- B-cell Lymphoma
- selinexor
- +6 more
- Bruxelles, Belgium
- +7 more
2021-07-23
Jul 23, 2021K
Terminated
- Glioblastoma
- Glioma
- Selinexor
- Boston, Massachusetts
- +5 more
2021-07-30
Jul 30, 2021